| Dr Robert Matthew Monberg, MD | |
|
3788 University Ave S Ste 304, Fairbanks, AK 99709-4680 | |
| (907) 456-4825 | |
| (907) 456-4899 |
| Full Name | Dr Robert Matthew Monberg |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 3788 University Ave S Ste 304, Fairbanks, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679548747 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | MEDS3855 (Alaska) | Primary |
| Entity Name | Tanana Valley Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922559558 PECOS PAC ID: 5698056901 Enrollment ID: O20161228001991 |
News Archive
A clinical trial of same-day initiation of antiretroviral therapy (ART) for HIV patients in South Africa led to a higher proportion of people starting treatment and to better health outcomes, according to a new study led by a Boston University School of Public Health researcher.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
American International Biotechnology Services™ announces the launch of its Absolute Match™ DNA specimen verification test. The test, which will be performed through AIBioTech's Fairfax Identity Laboratories™ division, provides absolute confidence for a patient undergoing a biopsy procedure that their specimen and diagnosis is their own.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Matthew Monberg, MD 3788 University Ave S Ste 304, Fairbanks, AK 99709-4680 Ph: (907) 456-4825 | Dr Robert Matthew Monberg, MD 3788 University Ave S Ste 304, Fairbanks, AK 99709-4680 Ph: (907) 456-4825 |
News Archive
A clinical trial of same-day initiation of antiretroviral therapy (ART) for HIV patients in South Africa led to a higher proportion of people starting treatment and to better health outcomes, according to a new study led by a Boston University School of Public Health researcher.
New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.
American International Biotechnology Services™ announces the launch of its Absolute Match™ DNA specimen verification test. The test, which will be performed through AIBioTech's Fairfax Identity Laboratories™ division, provides absolute confidence for a patient undergoing a biopsy procedure that their specimen and diagnosis is their own.
A new Scientific Statement issued today by The Endocrine Society represents a comprehensive evaluation of available information on the prevalence and medical consequences of the use of performance-enhancing drugs. The statement highlights the clinical pharmacology, adverse effects and detection of many substances often classified as PEDs, identifies gaps in knowledge and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
› Verified 7 days ago
Dr. Nicholas Paul Cosentino, D.O General Practice Medicare: Accepting Medicare Assignments Practice Location: 1650 Cowles St, Fairbanks, AK 99701 Phone: 907-458-5358 | |
Larry Allen Harikian, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1867 Airport Way, Ste 130b, Fairbanks, AK 99701 Phone: 907-452-2178 Fax: 907-452-3524 | |
Tamara Leigh Weaver, N.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 222 Front St, Fairbanks, AK 99701 Phone: 907-451-7100 |